Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases
Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases
Not yet recruiting · NCT07406126 · Registry updated 2026-02-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Not yet recruiting | Not stated | 2026-02-12 | NCT07406126 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boston Scientific International S.A. | 2 |
| Fernando Gómez Muñoz | 1 |
| Instituto de Investigacion Sanitaria La Fe | 16 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Provincial de Castellón | Castelló | Spain | 1 |
| Hospital Universitario de Navarra | Pamplona | Spain | 4 |
| Hospital Universitario Ramón y Cajal | Madrid | Spain | 42 |
| Hospital Universitario Virgen de las Nieves | Granada | Spain | 22 |
| Hospital Universitario y Politécnico La Fe | Valencia | Spain | 15 |